BRIEF-Jamjoom Pharma Updates On Non-Binding Term Sheet With Pharmaceutical Investment Company

JAMJOOM PHARMA

JAMJOOM PHARMA

4015.SA

0.00

July 23 (Reuters) - Jamjoom Pharmaceuticals Factory Company SJSC 4015.SE:

  • JAMJOOM PHARMA - UPDATES ON NON-BINDING TERM SHEET WITH PHARMACEUTICAL INVESTMENT COMPANY

  • JAMJOOM PHARMA - LIFERA INCORPORATING BIOLOGICS CO, AND CO WILL SUBSCRIBE FOR SHARES IN BIOLOGICS CO INSTEAD OF DIRECTLY ESTABLISHING JV

  • JAMJOOM PHARMA - JAMJOOM PHARMA WILL SUBSCRIBE FOR 4,900 NEW SHARES IN BIOLOGICS CO

  • JAMJOOM PHARMA - UPON COMPLETION, OWNERSHIP OF BIOLOGICS COMPANY WILL BE 51% HELD BY LIFERA AND 49% HELD BY JAMJOOM PHARMA

  • JAMJOOM PHARMA-TOTAL SUBSCRIPTION NOMINAL VALUE FOR JAMJOOM PHARMA IN (4,900) NEW SHARES IN BIOLOGICS CO AMOUNTS TO SAR 490,000

Source text: ID:nSSE3JG3Yw

Further company coverage: 4015.SE


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.